UBS Group
TBI

UBS Group’s Trueblue TBI Stock Holding History

UBS Group’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8K Sell
8,006
-2,605
-25% -$14.5K ﹤0.01% 7502
2026
Q1 		$41.5K Buy
10,611
+311
+3% +$1.38K ﹤0.01% 7492
2025
Q4 		$46.9K Sell
10,300
-71,430
-87% -$366K ﹤0.01% 7255
2025
Q3 		$501K Buy
81,730
+71,363
+688% +$451K ﹤0.01% 6097
2025
Q2 		$67.2K Sell
10,367
-11,044
-52% -$59.5K ﹤0.01% 7539
2025
Q1 		$114K Sell
21,411
-241,413
-92% -$1.65M ﹤0.01% 6958
2024
Q4 		$2.21M Buy
262,824
+243,696
+1,274% +$1.88M ﹤0.01% 4635
2024
Q3 		$151K Buy
19,128
+7,433
+64% +$66.9K ﹤0.01% 6067
2024
Q2 		$120K Sell
11,695
-55,464
-83% -$601K ﹤0.01% 6045
2024
Q1 		$841K Buy
67,159
+20,717
+45% +$268K ﹤0.01% 4741
2023
Q4 		$712K Buy
46,442
+45,376
+4,257% +$634K ﹤0.01% 4789
2023
Q3 		$15.6K Sell
1,066
-22,271
-95% -$347K ﹤0.01% 6928
2023
Q2 		$413K Sell
23,337
-28,432
-55% -$482K ﹤0.01% 4981
2023
Q1 		$921K Buy
51,769
+15,027
+41% +$281K ﹤0.01% 4184
2022
Q4 		$719K Buy
36,742
+19,309
+111% +$391K ﹤0.01% 4375
2022
Q3 		$333K Buy
17,433
+16,879
+3,047% +$341K ﹤0.01% 4693
2022
Q2 		$10K Sell
554
-9,035
-94% -$212K ﹤0.01% 8005
2022
Q1 		$277K Sell
9,589
-6,777
-41% -$186K ﹤0.01% 5125
2021
Q4 		$453K Buy
16,366
+13,253
+426% +$375K ﹤0.01% 5055
2021
Q3 		$84K Buy
3,113
+200
+7% +$5.35K ﹤0.01% 5948
2021
Q2 		$82K Sell
2,913
-20,698
-88% -$551K ﹤0.01% 6036
2021
Q1 		$520K Buy
23,611
+768
+3% +$15.7K ﹤0.01% 4836
2020
Q4 		$427K Buy
22,843
+9,104
+66% +$164K ﹤0.01% 4719
2020
Q3 		$213K Sell
13,739
-14,942
-52% -$230K ﹤0.01% 4764
2020
Q2 		$438K Sell
28,681
-126,288
-81% -$1.88M ﹤0.01% 4258
2020
Q1 		$1.98M Sell
154,969
-21,017
-12% -$376K ﹤0.01% 2773
2019
Q4 		$4.23M Buy
175,986
+11,234
+7% +$256K ﹤0.01% 2758
2019
Q3 		$3.48M Buy
164,752
+24,593
+18% +$508K ﹤0.01% 2736
2019
Q2 		$3.09M Buy
140,159
+77,414
+123% +$1.8M ﹤0.01% 2753
2019
Q1 		$1.48M Sell
62,745
-20,904
-25% -$488K ﹤0.01% 3259
2018
Q4 		$1.86M Buy
83,649
+2,008
+2% +$48.2K ﹤0.01% 3111
2018
Q3 		$2.13M Buy
81,641
+58,211
+248% +$1.62M ﹤0.01% 3173
2018
Q2 		$632K Buy
23,430
+19,078
+438% +$505K ﹤0.01% 4143
2018
Q1 		$113K Sell
4,352
-2,030
-32% -$55.5K ﹤0.01% 5147
2017
Q4 		$175K Sell
6,382
-92
-1% -$2.44K ﹤0.01% 5009
2017
Q3 		$145K Buy
6,474
+3,660
+130% +$82.8K ﹤0.01% 5075
2017
Q2 		$75K Sell
2,814
-55,029
-95% -$1.47M ﹤0.01% 5369
2017
Q1 		$1.58M Buy
57,843
+337
+0.6% +$8.6K ﹤0.01% 3147
2016
Q4 		$1.42M Buy
57,506
+53,339
+1,280% +$1.12M ﹤0.01% 3237
2016
Q3 		$95K Buy
4,167
+2,815
+208% +$61.5K ﹤0.01% 5027
2016
Q2 		$26K Sell
1,352
-6,631
-83% -$138K ﹤0.01% 6079
2016
Q1 		$209K Buy
7,983
+6,337
+385% +$147K ﹤0.01% 4462
2015
Q4 		$42K Buy
1,646
+40
+2% +$1.08K ﹤0.01% 5977
2015
Q3 		$36K Sell
1,606
-25,213
-94% -$647K ﹤0.01% 6114
2015
Q2 		$802K Buy
26,819
+20,157
+303% +$568K ﹤0.01% 3738
2015
Q1 		$162K Buy
6,662
+5,066
+317% +$114K ﹤0.01% 5037
2014
Q4 		$35K Buy
+1,596
New +$37.9K ﹤0.01% 6939

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IH
IES Holdings Houston, Texas $311M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's TBI Position: Q2 2026 in Review

UBS Group reduced its Trueblue (TBI) stake by 25% in Q2 2026, selling an estimated $14.5K and leaving 8,006 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7502.

UBS Group first reported a position in TBI in Q4 2014 and has held it in 47 quarters since. The position peaked at $4.23M in Q4 2019. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • UBS Group held 8,006 shares of Trueblue worth $55.8K as of Q2 2026.
  • UBS Group sold 2,605 Trueblue shares in Q2 2026, an estimated $14.5K.
  • Trueblue made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7502 holding.
  • UBS Group first reported a position in Trueblue in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Trueblue position peaked at $4.23M in Q4 2019.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.